REFRACTORY PLASMA CELL MYELOMA
Clinical trials for REFRACTORY PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for REFRACTORY PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough myeloma: Three-Drug combo trial launches
Disease control Recruiting nowThis study tests whether adding leflunomide to two standard drugs (pomalidomide and dexamethasone) can better control multiple myeloma that has come back or is resistant to treatment. About 29 adults with this type of blood cancer will receive the three-drug combination. The goal…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
Targeted radiation zaps myeloma cells in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment for multiple myeloma that has returned or not responded to standard therapy. The treatment combines a cancer-targeting antibody with a radioactive payload to deliver radiation directly to cancer cells. About 15 participants will receiv…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Virus-Based therapy targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase trial tests a genetically modified virus (VSV-IFNβ-NIS) alone or with chemotherapy and immunotherapy drugs in people with blood cancers like multiple myeloma, acute myeloid leukemia, and lymphomas that have returned or not responded to treatment. The virus is des…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Engineered immune cells take aim at Hard-to-Treat multiple myeloma
Disease control Recruiting nowThis early-phase study tests a new treatment for adults with a type of blood cancer called multiple myeloma that has returned or stopped responding to standard therapies. The treatment involves taking a patient's own immune cells, modifying them in a lab to recognize and attack m…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Simple lifestyle changes may improve myeloma outcomes, new study suggests
Symptom relief Recruiting nowThis study looks at whether non-drug approaches like physical activity, intermittent fasting, or adding a common beta-blocker (propranolol) can improve immune function and quality of life in people with multiple myeloma or related blood disorders. Researchers will measure changes…
Matched conditions: REFRACTORY PLASMA CELL MYELOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated May 17, 2026 03:11 UTC